Based on the opposite phenotype and co-localization in the subcellular compartment between PTP1B and PTP4A1, the beneficial potential of PTP4A1 in metabolic disorders such as NAFLD might be considerable. The gene discussed is PTP4A1; the disease is metabolic dysfunction-associated steatotic liver disease.